Publication | Open Access
Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study
68
Citations
36
References
2022
Year
CDX-0159 administration leads to systemic mast cell ablation and may represent a safe and novel approach to treat mast cell-driven disorders.
| Year | Citations | |
|---|---|---|
Page 1
Page 1